关于：每日一次服用5毫克他达拉非治疗≥75岁男性良性前列腺增生相关下尿路症状的疗效和安全性：来自多国、随机、安慰剂对照临床研究的汇总数据综合分析 - Suppr | 超能文献

Re: Efficacy and Safety of Tadalafil 5mg Once Daily in the Treatment of Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia in Men Aged ≥75 years: Integrated Analyses of Pooled Data from Multinational, Randomized, Placebo-controlled Clinical Studies.

作者信息

Madersbacher Stephan

机构信息

Urology Department, Kaiser-Franz-Josef Hospital, Vienna, Austria.

出版信息

Eur Urol. 2017 Jun;71(6):990. doi: 10.1016/j.eururo.2017.01.027. Epub 2017 Feb 2.

DOI:10.1016/j.eururo.2017.01.027

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Re: Efficacy and Safety of Tadalafil 5mg Once Daily in the Treatment of Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia in Men Aged ≥75 years: Integrated Analyses of Pooled Data from Multinational, Randomized, Placebo-controlled Clinical Studies.

Eur Urol. 2017 Jun;71(6):990. doi: 10.1016/j.eururo.2017.01.027. Epub 2017 Feb 2.

2

Efficacy and safety of tadalafil 5 mg once daily in the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in men aged ≥75 years: integrated analyses of pooled data from multinational, randomized, placebo-controlled clinical studies.

BJU Int. 2017 May;119(5):793-803. doi: 10.1111/bju.13744. Epub 2017 Jan 22.

3

Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men.

Int J Urol. 2013 Feb;20(2):193-201. doi: 10.1111/j.1442-2042.2012.03130.x. Epub 2012 Sep 7.

4

Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.

Eur Urol. 2011 Nov;60(5):1105-13. doi: 10.1016/j.eururo.2011.08.005. Epub 2011 Aug 12.

5

Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.

J Sex Med. 2013 Aug;10(8):2044-52. doi: 10.1111/jsm.12212. Epub 2013 Jun 19.

6

Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.

J Urol. 2013 Jan;189(1 Suppl):S135-40. doi: 10.1016/j.juro.2012.11.025.

7

Re: Efficacy and Safety of Tadalafil 5 mg Once Daily in the Treatment of Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia in Men Aged ≥75 Years: Integrated Analyses of Pooled Data from Multinational, Randomized, Placebo-Controlled Clinical Studies.

J Urol. 2018 Oct;200(4):675. doi: 10.1016/j.juro.2018.07.011. Epub 2018 Jul 12.

8

Time to onset of clinically meaningful improvement with tadalafil 5 mg once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: analysis of data pooled from 4 pivotal, double-blind, placebo controlled studies.

J Urol. 2015 May;193(5):1581-9. doi: 10.1016/j.juro.2014.11.094. Epub 2014 Nov 28.

9

Tadalafil 5 mg once-daily therapy for men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results from a randomized, double-blind, placebo-controlled trial carried out in Japan and Korea.

Int J Urol. 2014 Jul;21(7):670-5. doi: 10.1111/iju.12410. Epub 2014 Feb 27.

10

Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studies.

J Urol. 2014 Feb;191(2):405-11. doi: 10.1016/j.juro.2013.09.057. Epub 2013 Oct 1.

引用本文的文献

1

A Systematic Review and Meta-Analysis of the Efficacy and Safety of Tamsulosin Plus Tadalafil Compared With Tamsulosin Alone in Treating Males With Lower Urinary Tract Symptoms Secondary to Benign Prostrate Hyperplasia.

Am J Mens Health. 2023 Jan-Feb;17(1):15579883231155096. doi: 10.1177/15579883231155096.